Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NEWS

Aspirin may reduce death in hospitalized Covid-19 patients – Study

Aspirin may reduce death in hospitalized Covid-19 patients – Study

Washington, March 31(Prensa Latina) Researchers at the George Washington University published findings from the world's largest cohort study showing that hospitalized patients with moderate Covid-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Lead researcher, Jonathan Chow said, “This is our third study and the culmination of 15 months of work looking at aspirin use in hospitalized Covid-19 patients. We continue to find that aspirin use is associated with improved outcomes and lower rates of death in hospitalized patients.

What’s more, it’s low cost and readily available, which is important in parts of the world where more expensive therapeutics might not be as accessible.”

Researchers found a 1.6% reduction in mortality when aspirin was given within the first day of hospitalization in patients with moderate disease severity and that patients were less prone to forming blood clots.

They also found that elderly patients and patients with one or more comorbidities especially benefit from early aspirin therapy.

“This research is vital to providing physicians and patients effective and accessible COVID-19 treatments to help reduce in-hospital mortality rates and help people recover from this potentially devastating disease.”

mh/pll/acl/joe

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.